Synthesis and 2D-QSAR study of dispiropyrrolodinyl-oxindole based alkaloids as cholinesterase inhibitors
- 22 October 2018
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 83, 226-234
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's diseaseMedicinal Research Reviews, 2011
- Asymmetric Syntheses of Oxindole and Indole Spirocyclic Alkaloid Natural ProductsSynthesis, 2009
- Regioselective synthesis and stereochemical structure of anti-tumor active dispiro[3H-indole-3,2′-pyrrolidine-3′,3″-piperidine]-2(1H),4″-dionesEuropean Journal of Medicinal Chemistry, 2009
- Regioselective synthesis of dispiro[1H-indene-2,3′-pyrrolidine-2′,3″-[3H]indole]-1,2″(1″H)-diones of potential anti-tumor propertiesEuropean Journal of Medicinal Chemistry, 2009
- The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug DevelopmentThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Construction of Spiro[pyrrolidine‐3,3′‐oxindoles] − Recent Applications to the Synthesis of Oxindole AlkaloidsEuropean Journal of Organic Chemistry, 2003
- Review: Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and NeurotoxicityJournal of Structural Biology, 2000
- Acetylcholinesterase inhibitors in Alzheimer’s diseaseBritish Journal of Clinical Pharmacology, 1999
- Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the EnzymeNeuron, 1996
- Biological markers and the cholinergic hypothesis in Alzheimer's diseaseActa Neurologica Scandinavica, 1992